HEB, Hemispherx Biopharma (AMEX)NEW Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MarcG who wrote ()	1/17/1999 5:52:00 AM
From: Bart Goemaere	of 857

Just been to the press-conference of RED Laboratories ... Lessius, TrustCapital Partners, Beluga, Quadra Invest and another venture capitalists are making an investment of 110 mio BF in RED Laboratories to prepare for the commercialization of a testkit for CFS. They expect ampligen to be approved in Europe soon. The market for CFS persons in Europe is estimated at 300 000 people ( which they said was a worst case estimate), 100 000 people could be treated with Ampligen. Professor De Meirleer said that the previous use of Ampligen caused illnes and other side effects. This was due to the wrong production of Ampligen ...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next